Several epithelial tissues contain stem cell reserves to replenish cells lost during normal homeostasis or upon injury. However, how epithelial tissues respond to distinct types of damage, and how stem cell plasticity and proliferation are regulated in these contexts, remain poorly understood. Here, we reveal that genotoxic agents, but not mechanical damage, induce hyperplasia and lineage infidelity in three related epithelial tissues: the mammary gland, interfollicular epidermis and hair follicle. Furthermore, DNA damage also promotes stromal proliferation. In the mammary gland, we find that DNA damage activates multipotency within the myoepithelial population and hyper-proliferation of their luminal progeny, resulting in tissue disorganization. Additionally, in epidermal and hair follicle epithelia, DNA damage induces basal cell hyperplasia with the formation of abnormal, multi-layered K14+/K10+ cells.
INTRODUCTION
The mammary epithelium arises from the embryonic epidermis, and is composed primarily of two distinct layers, an outer (basal) layer of contractile myoepithelial cells positive for keratin 14 (K14+) and an inner layer of luminal cells positive for keratin 8 (K8+). Lineage-tracing has shown that although the embryonic mammary gland develops from bipotent stem cells, postnatally each cell type is maintained by distinct unipotent progenitors [1] [2] [3] [4] . Strikingly, however, the myoepithelial cells become highly plastic when dissociated from their native tissue 1, 2, [5] [6] [7] [8] [9] , such that a single transplanted cell can regenerate a complete mammary ductal tree within the cleared fat pad of a recipient mouse 6, 7 . A similar loss of fate restriction has been observed in the skin. Stem cells within the bulge of the hair follicle do not normally give rise to the infundibulum, interfollicular epidermis or sebaceous gland, but lose this restriction when isolated and engrafted onto a recipient mouse, where they can regenerate the entire skin epithelium 10 . Since this potential for multipotency is efficiently suppressed in unperturbed tissue, it begs the question of why such a property has been retained.
One possibility is that a reversion to stemness is needed in response to tissue damage, as a mechanism of wound healing. There is precedent for such a function in the skin, intestine and lung.
Hair follicle stem cells, for example, are rapidly recruited to the interfollicular epithelium after wounding, and function in short-term repair, though few contribute to the tissue over the longer-3 term 11, 12 . Moreover, if bulge cells are destroyed, hair germ cells can colonize the empty niche and mediate hair regeneration 13 . Similarly, in intestinal crypts, ablation of Lgr5+ stem cells triggers quiescent Bmi1+ cells to convert into Lgr5+ cells to maintain gut homeostasis 14 ; and in the lung, ablation of tracheal basal stem cells can trigger committed secretory cells to de-differentiate and replace them 15 . Therefore, we considered that the multipotency potential of mammary myoepithelial cells, identified through their isolation and transplantation, might represent a damage response.
RESULTS

DNA damage promotes multipotency in mouse mammary myoepithelial cells in situ
We first confirmed that K14+ myoepithelial cells are unipotent in their unperturbed in situ environment during morphogenesis, as reported previously [1] [2] [3] [4] . We used a doxycycline-inducible mouse model to perform saturation lineage-tracing of myoepithelial cell progeny (K14-rtTA; TetO-Cre; tdTomato fl/wt ) ( Fig.1A ) [16] [17] [18] . To promote tdTomato expression, we maintained the mice on doxycycline chow for six weeks from puberty onset (three-weeks old) before sacrifice and analysis (Fig.1B) . We performed fluorescence-activated cell sorting (FACS) analysis to determine the efficiency of tdTomato-positive myoepithelial cell labeling, as well as potential leakage into the luminal population.
We found an average of 81.8% tdTomato-positive myoepithelial cells and 0.9% tdTomato-positive luminal cells following the six-week treatment period, indicating that this transgenic system has very low leakage rates and successfully labels the majority of myoepithelial cells over this timeframe (Fig.S1V) . We also used a tamoxifen-inducible transgenic mouse model to lineage-trace K8+ luminal mammary cell progeny by injecting tamoxifen at puberty onset (K8-CreER; tdTomato fl/wt ) (Fig.S1S-T) 1 . Both myoepithelial and luminal cells were unipotent, corroborating published data (Figs.1D, S1U).
To test our hypothesis that tissue damage promotes mammary cell plasticity, we introduced two distinct types of damage in vivo: mechanical wounding or genotoxicity. We used one mammary fat pad for the experimental condition, and another in the same mouse as an internal control (Fig.1C) .
For mechanical wounding, we made deep lacerations throughout the mammary tissue using a scalpel. Alternatively, we injected a DNA crosslinking agent directly into the mammary fat pad. We performed these interventions on three-week old pubertal mice, then followed the same feeding and analysis regimen described above (Fig.1B) . Surprisingly, mechanical wounding had no impact on mammary architecture or myoepithelial cell behavior, as determined by lineage-tracing, and their unipotency was maintained (Figs.1E-F, S2A-D). However, unlike vehicle, DNA damage (induced by the chemotherapeutic agents Cisplatin or Mitomycin C) triggered a remarkable disruption of myoepithelial lineage specification (Figs.1G-H, S1A-R). Large numbers of tdTomato+ cells derived from the myoepithelium were generated (Figs.1H, S1B-J, L-R), positive for the luminal marker E-4 cadherin (Fig.1H) . Furthermore, this unexpected response to DNA damage resulted in the perturbation of normal epithelial architecture, as the tdTomato+ cells had displaced into and filled up the lumens (Figs.1G-H, S1A-R, S2A-B, E-H) . Notably, this luminal filling resembles ductal carcinoma in situ, an early pre-invasive stage of breast cancer 19, 20 .
In contrast with these in vivo findings, treating EpH4 mammary epithelial cells in culture with
Cisplatin or Mitomycin C caused cell death, as expected (Fig.1K ) 21 . 1L ).
Taken together, these experiments reveal that DNA damaging agents, unlike mechanical wounding, cause a paradoxical hyperplasia and lineage infidelity in wild-type mammary epithelium in situ ( Fig.1I-J) . The striking differences between mammary cell responses in vivo and ex vivo suggest that the tissue microenvironment may play a critical role in the tissue response to DNA damage.
DNA damage promotes hyper-proliferation and lineage infidelity in intact mouse epidermis
We next asked if these responses to DNA damage are mammary-specific or generalizable to other epithelial tissues. The mammary gland is a sub-appendage of the epidermis, as mammary placodes first emerge from epidermal epithelium during embryogenesis. However, the two tissues diverge in architecture and cell lineage pathways. K14+ basal cells of the epidermis are bipotent, balancing between self-renewal and production of non-proliferative K10+ suprabasal cells that terminally differentiate to form an impenetrable skin barrier 22 . Notably, basal cells in adult epidermis have very low proliferation rates (Fig. 2D , BrdU channel). To determine how the epidermis responds to mechanical damage, we scraped the backskin of 3-6 week old wild-type adult mice, and analyzed the wounded skin region after one week. We found no significant alterations in epidermal cell organization, tissue thickness or proliferation (based on BrdU+ staining), compared to untouched, age-matched control tissue ( Fig.2A, D-E) . However, one week after Cisplatin 'painting' onto shaved and scraped backskin (Fig.2B) , the gross tissue exhibited a rough, scabbed and scaly appearance compared to vehicle (Fig.S3Q-R) . To test for DNA damage, we stained skin sections for H2AX and detected positive cell nuclei within the basal layer 1 day post-treatment, as compared to control 5 tissue, which was H2AX-negative ( Fig.S3G-H) . Notably, a significant number of dermal cells also stained positive for H2AX following Cisplatin treatment (Fig.S3G-H) .
To probe for a proliferative response to Cisplatin, we used BrdU pulse-labeling. Tissue analysis 7 days post-treatment revealed a substantial increase in BrdU+ basal cells compared with vehicle (PBS)-treated controls ( Fig.2E-F) . Many dermal cells also showed BrdU labeling following Cisplatin treatment ( Fig.2E-F) . Expression of the apoptotic marker cleaved caspase-3 was absent from tissue both 1 and 2 days post-treatment, suggesting that these responses were not a compensatory reaction to apoptosis (Fig.S3A-D) .
Strikingly, Cisplatin treatment caused a massive expansion of the suprabasal layers, with the majority of cells staining double-positive for K14 and K10, a state that is only rarely detected in normal epidermis (Fig.2E-F) . The stem cell marker p63, normally confined to the basal cell layer, was inappropriately expressed throughout these expanded layers despite their lack of BrdU+ labeling, suggesting defective differentiation ( Fig.2H-I ). Nonetheless, these cells maintained robust basolateral expression of E-cadherin, demonstrating retention of their polarity and epithelial identity ( Fig.S3T-U) .
The Cisplatin-treated tissue also appeared to be under stress, as indicated by positive keratin 6 (K6) staining in the interfollicular epidermis that is entirely absent from control tissue ( Fig.S3V-W) .
Importantly, Cisplatin-induced hyper-proliferation and lineage infidelity were not dependent on hair follicle stage, as DNA-damaged skin containing hair follicles in either the growth (anagen) or resting Cisplatin treatments were applied to separately shaved backskin regions of the same mouse, partitioned only by a tuft of hair (Fig.S3P ).
The increase in tissue thickness of Cisplatin-treated skin peaked between 5 -7 days posttreatment (Fig.2G ). This response then waned over a period of 5 weeks (Fig.S4A ). In addition, backskin exposed to a second round of Cisplatin treatment was also able to resolve back to its original thickness (Fig. S4B ). These observations suggest that the epithelial response to Cisplatin is reversible, and that no oncogenic transformation occurs, at least over the short term. We conclude that hyper-proliferative basal cells activated by Cisplatin eventually lose their proliferative capacity, apoptose, and/or undergo differentiation and are ultimately shed.
To confirm that the massively expanded suprabasal population came from the hyper-proliferative basal cells, we performed pulse-chase experiments using the K14-rtTA; TetO-Cre; tdTomato lineagetracing mouse line described above (Fig.1A) . This pulse-chase approach was necessary to ensure that only the progeny of cells originating in the basal population would be traced, since all cells following Cisplatin treatment express K14. We both fed and injected mice with doxycycline over a 6 one-week period, then transferred them to a normal diet after Cisplatin painting, and collected samples one week later (Fig. 2C) . While tdTomato expression in vehicle-painted backskin was confined to the basal layer, all cell layers in the Cisplatin-painted backskin retained the tdTomato label, thus confirming that the expanded suprabasal population was generated from hyperproliferative basal cells as opposed to pre-existing suprabasal cells (Fig. S3E-F Stromal components of the mammary fat pad are essential for promoting mammary gland morphogenesis and remodeling 27, 28 ; epidermal wound healing requires dermal fibroblast recruitment into the wound bed; and hair follicle morphogenesis depends on extensive epithelial-mesenchymal crosstalk 29 . Notably, microenvironmental signals can also promote epithelial tumorigenesis. Cancerassociated fibroblasts (CAFs) have been linked to the progression of both triple-negative breast 7 cancer and basal cell carcinoma [30] [31] [32] . To test whether DNA damage to stromal cells can elicit the epithelial behaviors observed in vivo, we first injected Cisplatin under the skin epithelium directly into the dermis ("intradermal injection"), and analyzed the tissue one week post-injection (Fig.3C ). Similar to our previous scraping and painting approach, this treatment induced both dermal and epithelial hyper-proliferation, causing significant epidermal thickening and lineage infidelity compared with vehicle ( Fig.3A-B, D) . These data indicate that DNA damage alone, in the absence of wounding, is sufficient to promote a response. Notably, intradermal injections promoted hyper-proliferation and lineage infidelity down the outer root sheath of the hair follicle, with the follicular epithelium expressing both K14 and K10 (typically absent from normal hair follicles) ( Fig.3A-B) . Furthermore, the bottommost region of the anagen hair follicle (normally composed of proliferative BrdU+ matrix cells that give rise to all inner layers of the differentiated hair shaft) showed no BrdU labeling, and also co- To identify the dermal component(s) promoting these epithelial behaviors, we took a candidate approach. Psoriasis is a chronic, inflammatory skin disease caused by overactive innate and adaptive immune responses, and psoriatic skin, like Cisplatin-treated skin, exhibits keratinocyte hyperproliferation, hyperkeratinosis and defective cell differentiation 33 . Therefore, we tested whether immune cells are involved in the epidermal Cisplatin response by treating the backskin of immunocompromised NOD scid gamma (NSG) mice, which lack both adaptive and innate immune function. Contrary to expectations, we found that gross tissue scabbing, hyper-proliferation, tissue thickening, and lineage infidelity still occurred in these mice following Cisplatin treatment, demonstrating that immune cells are not required for the Cisplatin effect ( Fig.3I-N ) 34, 35 . This particularly striking finding challenges current dogma that immune cells, particularly T cells, are critical for mounting efficient skin responses to injury 36 . Furthermore, since macrophages and dendritic cells phagocytose apoptotic cells, we reasoned that the lack of apoptotic cells observed in wild-type Cisplatin-treated backskin could be due to their rapid clearing by these immune scavengers 37 . After staining Cisplatin-treated NSG backskin (that lack macrophage and dendritic activity) with cleaved caspase-3, however, we still did not detect the presence of apoptotic cells ( Fig.3O-P) .
Dermal fibroblasts are necessary and sufficient for the epithelial response to DNA damage 8 An alternative candidate cell type that could drive the epithelial response to DNA damage is the dermal fibroblast, which can stimulate keratinocyte proliferation, and is important for epidermal morphogenesis, maintenance and regeneration 38, 39 . To determine whether fibroblasts are required for the epithelial response to Cisplatin, we ablated them by pre-treating Col1a2-CreER; DTA (Diphtheria toxin A) mice with 4-Hydroxytamoxifen (4OHT), then treated their backskin with Cisplatin (Fig.4A ) 40 . In this system, 4OHT promotes Diphtheria toxin A activation in, and subsequent killing of, Col1a2+ fibroblasts (Fig.4B ). Col1a2-CreER; DTA mice pretreated with vehicle and then treated with
Cisplatin exhibited a hyper-proliferative response similar to that of wild-type Cisplatin-treated mice, whereas fibroblast ablation with 4OHT caused a dramatic decrease in proliferation, epidermal thickening, and lineage infidelity ( Fig.4C-E) . We conclude that fibroblasts are necessary to drive the epithelial responses to Cisplatin.
Probing further, we performed a converse experiment by transplanting fibroblasts from Cisplatintreated dermis into the dermis of syngeneic recipients. We first confirmed that transplanted fibroblasts and keratinocytes (used as a negative control) survived post-transplantation and were positioned properly in the recipient dermal region by tracking cells with a CFSE fluorescent label ( Fig.4F-G) . We then performed separate transplantation experiments using fibroblasts isolated from untreated and Cisplatin-treated mice, and assessed epidermal cell behavior 3 days post-transplantation (Fig.4H ).
We also transplanted keratinocytes from the same donor mice or injected media as additional controls. Strikingly, the fibroblast transplantations, unlike control keratinocytes and media, were sufficient to trigger hyper-proliferation, tissue thickening and lineage infidelity (Fig.4I-L) . Interestingly, the isolation and transplantation of fibroblasts from untreated mice was sufficient to promote some epidermal thickening and lineage infidelity, though to a significantly lesser degree than fibroblasts from Cisplatin-treated mice (Fig.4I-L) . This result suggests that the isolation procedure alone can prime the fibroblasts, as has been observed for other cell types 9, 10 . Overall, we conclude that epithelial activation by DNA damaging agents is cell non-autonomous, and that dermal fibroblasts are both necessary and sufficient to drive this response ( Fig.S4C-D) .
DISCUSSION
We have discovered a counter-intuitive effect of genotoxic agents on epithelial tissues in vivo.
Chemotherapeutic DNA crosslinking agents that block cell proliferation and trigger apoptosis in culture have the opposite effects in the intact skin and mammary gland, promoting epithelial hyperplasia and lineage infidelity. Unexpectedly, this response is cell non-autonomous, but is independent of both innate and adaptive immunity. We found that, instead, dermal fibroblasts are both necessary and sufficient to drive the epithelial response. We propose that in response to DNA damage, the fibroblasts release factors that stimulate epithelial cell hyper-proliferation, which in turn causes defects in lineage specification (Fig.S4C-D) . Whether a similar mechanism accounts for lineage switching in the mammary gland remains to be established.
The de-repression of cell plasticity in mammary glands subjected to DNA damage is reminiscent of mammary cell reprogramming into multipotent stem cells upon dissociation from their native tissue 1, 2, 5-8 . Oncogenic activation of unipotent mammary cells in situ can also promote multipotency 41 .
Similarly, in both the interfollicular and follicular epidermal compartments, we show that DNA damage promotes hyperplasia and lineage infidelity, underscoring the generalizability of the effect across multiple epithelial tissue types. This response does not require innate or adaptive immunity 42 , but the hyperkeratinosis phenotype is nonetheless similar to that seen in immune and inflammation-triggered skin diseases such as psoriasis and atopic dermatitis, and in experimentally-induced inflammation 43 , demonstrating how multiple cellular mechanisms driven by distinct molecular pathways can converge to cause similar gross tissue pathologies.
The drugs Cisplatin and Mitomycin C used in this study generate interstrand and intrastrand DNA crosslinks that block replication and transcription. They are used therapeutically for a variety of epithelial cancers, by promoting apoptosis of rapidly cycling tumor cells [44] [45] [46] [47] [48] . Strikingly, however, aside from work on Cisplatin-induced nephrotoxicity, most studies characterizing the effects of genotoxic agents on cell behavior have been limited to cancer cell lines in culture 21, 49 . Although DNA damage was previously reported to cause defective differentiation in cultured mammary epithelial cell lines, the relevance of these ex vivo responses to in vivo mammary tissue is unclear 50 . We speculate that genotoxic crosslinking agents do not induce apoptosis in vivo because, contrary to the situation in culture, most epidermal cells are not cycling, so replication forks will only rarely collide with the crosslinks to activate the damage repair pathway. Other transcription-coupled repair mechanisms, however, might protect the cells and enable them, after sufficient time, to begin proliferation. Although we find that the in vivo responses to DNA damage ultimately resolve over time, plasticity and hyperplasia coupled with DNA damage is an established mechanism for tumor initiation 51 . Platinum compounds remain widely used in cancer chemotherapy for adjuvant or neoadjuvant treatment and metastatic disease, so our results raise significant concerns about unanticipated side-effects.
F32CA21374 to LS and T32CA119925 to LS, as well as American Cancer Society grant PF-18-007-01-CCG to LS.
MATERIALS AND METHODS
Mouse lines
The mouse lines acquired from Jackson Laboratory (Bar Harbor, ME) for this study include: K14-rtTA (JAX stock # 008099) 16 , (tetO)7-Cre ("TetO-Cre") (Jax stock # 006234) 17 , Ai9 ("tdTomato") (JAX stock # 007909) 18 , K8-CreER (JAX stock # 017947) 1 , NSG (JAX stock # 005557) 34, 35 , Rosa26-DTA176
("DTA") (JAX stock # 010527) 52 , Col1a2-CreER (JAX stock # 029567) 40 , and R26R-Confetti ("Confetti")
(JAX stock # 013731) 25, 26 . C3H mice (Strain code 025) were acquired from Charles River Laboratories 
Epidermal surgery and drug treatment
Following anesthesia administration, a razor was used to shave and make superficial abrasions (referred to throughout the text as "mechanical wounding" or "scrape") on the backskin of 3-6 wk old adult C3H and K14-rtTA; TetO-Cre; tdTomato/Confetti mice. Cisplatin (4mM) (BioVision, Inc., Milpitas, CA) or PBS (vehicle) was then spread ("painted") across the shaven region. For intradermal injections, a shaven region of backskin was pinched with forceps and a 26G needle was used to superficially inject 30uL of drug or vehicle into multiple regions within the shaved area. 
Cryosectioning, immunohistochemical staining and image acquisition
Fibroblast transplantation assay
Adult C3H mouse (3-6 wk donors) backskin was shaven, scraped and painted (as described above) with 4mM cisplatin or PBS vehicle and left for three days. Mice were then sacrificed and backskin was isolated, processed and maintained at 4°C overnight in 0.25% Trypsin-EDTA (ThermoFisher Scientific, Waltham, MA), as previously described 53 . Fibroblasts were isolated the following day, as previously described 54 . Fibroblasts were then injected into the dermis of adult C3H mice (3-6 wk syngeneic recipients). A total of 240,000 fibroblasts were injected per backskin (ten 30 µl intradermal injections of 24,000 cells spaced along different areas of the shaved region). Mice were left for three days before sacrifice and tissue analysis (see Timeline, Fig.4H ).
Fibroblast ablation assay
The backskin of Col1a2-CreER; DTA mice was shaven, scraped and painted with 4-Hydroxytamoxifen (4OHT) (Sigma-Aldrich, St. Louis, MO) or 100% ethanol (EtOH, vehicle) according to the timeline in Fig.4A . Following four consecutive days of 4OHT or EtOH treatment, the same shaven backskin region was re-scraped and repainted with 4OHT or EtOH in addition to 4mM cisplatin. Mice were then left for seven days before sacrifice and tissue analysis.
Pulse-chase experiments
For epidermal pulse-chase experiments, adult K14-rtTA; TetO-Cre; tdTomato/Confetti mice (3-6 wk old)
were injected with a total of 5 mg doxycycline over 5 days (dox pulses: day 1-2mg, day 3-2 mg, day 5-1 mg) while also on Dox Diet (see Timeline, Fig.2C ). A region of backskin was shaven, scraped and painted on day 7, and mice were switched onto a regular diet (chase) for 7 days before sacrifice and tissue analysis. For mammary pulse-chase experiments, K14-rtTA; TetO-Cre; tdTomato mice were injected with two pulses of 4.5mg doxycycline, the first at 4 wks old and the second at 7 wks old (Timeline, Fig.S1S ).
Cell culture treatments
EpH4 cells at 50% confluency (the same cell numbers were plated for each condition) were treated with 1 µM or 3 µM Cisplatin or Mitomycin C (or PBS and dH20 vehicles, respectively). After 24 hr incubation at 37°C and 5% CO2, drugs were washed off, cells were split, and 1 mL of each was plated into a separate 10 cm dish. Cells were imaged and counted 48 Cisplatin-treated telogen backskin responded similarly to Cisplatin-treated backskin in the anagen (growth) phase (all other epidermal data throughout this manuscript were generated from anagen backskin). This suggests that the epidermal Cisplatin response is independent of hair cycle phase.
Unless otherwise specified, all image panels in this figure correspond to the experimental timeline presented in Fig.2A . Scale bars are 10 µm (*) or 50 µm. Re-scrape/ re-paint
